MedCost Clear Cost calculator

Drugs / Humira

Humira cost

adalimumab · AbbVie. Every official price for Humira, side by side, with who pays it.

Short answer

We found no list price published by AbbVie. Pharmacies paid an average of $3,366.95–$6,735.20 per pen or syringe (NADAC, Oct 21, 2026). With the pharmacy coupon on TrumpRx.gov, Humira is $950 for 2 pens or syringes (paying without insurance). In 2024, Medicare Part D spent $5.7 billion on Humira, an average of $8,766.28 per prescription fill before rebates (CMS). In Medicare Part D, the yearly out-of-pocket limit is $2,100 in 2026 and $2,400 in 2027.145723

Source: CMS, data.medicaid.gov (NADAC) and Medicare.gov · checked Nov 15, 2026

Humira: the official numbers, by situation

PriceAmountWhose price, and who it applies toDate
List price Not published We found no list price published by AbbVie. —
TrumpRx.gov cash price
Pen 40/0.4 mg/mL, qty 2
$950.004 Pharmacy coupon. Paying without insurance. Nov 15, 2026
TrumpRx.gov cash price
Prefilled Syringe 10/0.1 mg/mL, qty 2
$950.005 Pharmacy coupon. Paying without insurance. Nov 15, 2026
Pharmacy cost (NADAC)
per pen or syringe; a month depends on your dose
$3,366.95–$6,735.201 What pharmacies pay on average (CMS survey). Not a patient price. Oct 21, 2026

On Medicare drug coverage: 1,248 of 5,492 Part D plans list Humira for 2027 (23%), and 100% of those require prior authorization, in CMS's formulary file published Oct 15, 2026.13 By year and tier

None of these is your price at the counter: that depends on how you pay. Details and sources for each number are further down.

FDA approval

Every official price

PriceAmountWhat it isDate
Maker's list price (WAC) Not published We found no current list price on AbbVie's own pages, so we do not show one. —
Pharmacy acquisition cost (NADAC)
Humira 40 mg/0.8 mL syringe
$3,368.961 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Humira pen 40 mg/0.8 mL
$3,366.951 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Humira(CF) 40 mg/0.4 mL syringe
$3,368.441 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Humira(CF) pen 40 mg/0.4 mL
$3,367.851 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026
Pharmacy acquisition cost (NADAC)
Humira(CF) pen 80 mg/0.8 mL
$6,735.201 Per tablet or capsule in the pack. The national average price pharmacies pay to buy it. Oct 21, 2026

These are prices the drug company, Medicare and pharmacies use. What you pay depends on your coverage; see below.

Humira on TrumpRx.gov

ListingHow soldTrumpRx priceOptions (as listed)Checked
Humira® PenPharmacy coupon$950.004
Pen 40/0.4 mg/mL, qty 2: $950.00
Nov 15, 2026
Humira® Prefilled SyringePharmacy coupon$950.005
Prefilled Syringe 10/0.1 mg/mL, qty 2: $950.00
Prefilled Syringe 20/0.2 mg/mL, qty 2: $950.00
Prefilled Syringe 40/0.4 mg/mL, qty 2: $950.00
Nov 15, 2026

Pharmacy coupon: shown at a pharmacy; the pharmacy confirms the final price. Cash prices; they don't go through insurance. Every TrumpRx price.

What Medicare spent on Humira in 2024

CMS publishes what Part D spent on each drug each year. Its spending is the gross drug cost, which includes what Medicare, the plan and the patient paid,8 and it does not reflect manufacturers' rebates.9 CMS lists Humira in 6 rows; together they come to $5.7 billion over 652,028 prescription fills, $8,766.28 per fill.

Medicare Part D, calendar year 2024 (CMS Medicare Part D Spending by Drug, checked Nov 15, 2026).

Product (as CMS lists it)Total spendingFillsPeoplePer fillPer person
Humira $208.9 million7 25,521 3,912 $8,185.6210 $53,401.1111
Humira Pen $697.4 million7 85,167 11,719 $8,188.6810 $59,510.6411
Humira(Cf) $400.9 million7 46,620 6,661 $8,599.3210 $60,186.2311
Humira(Cf) Pen $4.3 billion7 490,303 63,768 $8,828.6210 $67,881.9911
Humira(Cf) Pen Crohn'S-Uc-Hs $59.2 million7 2,890 2,792 $20,489.9310 $21,209.1311
Humira(Cf) Pen Psor-Uv-Adol Hs $20.7 million7 1,527 1,497 $13,580.5210 $13,852.6811

These are totals and averages across everyone in Medicare who used the drug, not a price for one person. Averages per person depend on how long and how much each person used it.

How many Medicare Part D plans list Humira

Every Medicare drug plan in CMS's formulary file (standalone drug plans and Medicare Advantage plans with drug coverage). A plan counts when its drug list has at least one form or strength. Matched by RxNorm code and checked against the FDA NDC Directory. Plan counts, not people; to see your own plan's rules use Medicare Plan Finder.

Plan yearWhatPlans that list itPrior auth.Step therapyQuantity limitLowest tier (plans)
2026Humira (brand) 2,901 of 5,49612
53%
2,90102,751 tier 1: 91 · tier 2: 1 · tier 4: 46 · tier 5: 2,763
2026Any adalimumab biosimilar 5,466 of 5,49612
99%
5,34405,159 tier 1: 161 · tier 2: 2 · tier 3: 144 · tier 4: 50 · tier 5: 5,109
2026Humira or a biosimilar 5,496 of 5,49612
100%
5,37405,189 tier 1: 161 · tier 2: 2 · tier 3: 144 · tier 4: 50 · tier 5: 5,139
2027Humira (brand) 1,248 of 5,49213
23%
1,24801,131 tier 1: 31 · tier 4: 40 · tier 5: 1,177
2027Any adalimumab biosimilar 5,492 of 5,49213
100%
5,37305,240 tier 1: 123 · tier 2: 1 · tier 3: 756 · tier 4: 190 · tier 5: 4,422
2027Humira or a biosimilar 5,492 of 5,49213
100%
5,37305,240 tier 1: 123 · tier 2: 1 · tier 3: 756 · tier 4: 190 · tier 5: 4,422
2026: CMS file 2026_20260916.zip, published Sep 23, 2026 · 2027: CMS file 2027_20261008.zip, published Oct 15, 2026. Plans listing both Humira and a biosimilar: 2,871 for 2026, 1,248 for 2027.

Being on a plan's list is not a price: what you pay depends on the tier and your plan. Each plan can divide its tiers in different ways. What prior authorization, step therapy and tiers mean.

Humira and its biosimilars: what pharmacies pay (NADAC)

Each product's newest rate in our archived NADAC queries (newest weekly file Nov 11, 2026). Per pen or syringe. Not a patient price; a biosimilar is a separate product, and switching is a decision for you and your prescriber.

Product (NADAC description)Per pen or syringeRate effective
HUMIRA PEN 40 MG/0.8 ML$3,366.9514Oct 21, 2026
HUMIRA(CF) PEN 40 MG/0.4 ML$3,367.8514Oct 21, 2026
HUMIRA(CF) 40 MG/0.4 ML SYRINGE$3,368.4414Oct 21, 2026
HUMIRA 40 MG/0.8 ML SYRINGE$3,368.9614Oct 21, 2026
HUMIRA(CF) PEN 80 MG/0.8 ML$6,735.2014Oct 21, 2026
SIMLANDI(CF) 40 MG/0.4 ML SYRINGE$478.6518Aug 19, 2026
ADALIMUMAB-AATY(CF) 40 MG/0.4 ML SYRINGE$489.0915Oct 21, 2026
ADALIMUMAB-AATY(CF) 40 MG/0.4 ML AUTOINJECTOR$490.68–$499.1715Oct 21, 2026
HADLIMA 40 MG/0.8 ML SYRINGE$493.7116Oct 21, 2026
SIMLANDI(CF) 40 MG/0.4 ML AUTOINJECTOR$499.2518Oct 21, 2026
HADLIMA(CF) 40 MG/0.4 ML SYRINGE$503.2416Oct 21, 2026
HADLIMA(CF) PUSHTOUCH 40 MG/0.4 ML$503.7816Oct 21, 2026
HADLIMA PUSHTOUCH 40 MG/0.8 ML$506.3816Oct 21, 2026
ADALIMUMAB-ADAZ(CF) PEN 40 MG/0.4 ML$635.7615Oct 21, 2026
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.4 ML$638.9815Oct 21, 2026
ADALIMUMAB-ADBM(CF) PEN 40 MG/0.8 ML$639.4115Oct 21, 2026
ADALIMUMAB-AACF(CF) PEN 40 MG/0.8 ML (2 PACK)$872.6415Oct 21, 2026
YUFLYMA(CF) 40 MG/0.4 ML AUTOINJECTOR$896.51–$912.2117Oct 21, 2026
Cyltezo and Yusimry had no rate in the newest weekly file and are left out. Humira from $3,366.95; biosimilars from $478.65 per pen or syringe.

With Medicare

With commercial insurance or no insurance

Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.

Official sources for this page (20)
  1. “Out-of-pocket limit Yearly $2,100 (in 2026).”
    Medicare.gov: Medicare costs · as of Oct 23, 2026
  2. “Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
  3. TrumpRx.gov: Humira® Pen listing · as of Nov 15, 2026
  4. “BLA125057 ORIG-1 approved 20021231”
  5. “Humira: Tot_Spndng_2024 208905154.75, Tot_Clms_2024 25521, Tot_Benes_2024 3912; Humira Pen: Tot_Spndng_2024 697405207.41, Tot_Clms_2024 85167, Tot_Benes_2024 11719; Humira(Cf): Tot_Spndng_2024 400900510.75, Tot_Clms_2024 46620, Tot_Benes_2024 6661; Humira(Cf) Pen: Tot_Spndng_2024 4328698864.2, Tot_Clms_2024 490303, Tot_Benes_2024 63768; Humira(Cf) Pen Crohn'S-Uc-Hs: Tot_Spndng_2024 59215904.35, Tot_Clms_2024 2890, Tot_Benes_2024 2792; Humira(Cf) Pen Psor-Uv-Adol Hs: Tot_Spndng_2024 20737458.22, Tot_Clms_2024 1527, Tot_Benes_2024 1497”
  6. “Drug spending metrics for Part D drugs are based on the gross drug cost, which represents total spending for the prescription claim, including Medicare, plan, and beneficiary payments.”
  7. “The Part D spending metrics do not reflect any manufacturers' rebates or other price concessions as CMS is prohibited from publicly disclosing such information.”
  8. “Part D drug spending divided by the number of prescription fills.”
  9. “Total Part D drug spending divided by the number of unique beneficiaries utilizing the drug during the benefit year.”

Did this page answer your question?